Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
Canaan Inc. (NASDAQ:CAN) announced it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Stock Market. The update was disclosed in a press release statement included in a Form 6-K filing with the U.S. Securities and Exchange Commission.
According to the filing, Canaan received notification from Nasdaq indicating that the company has met the minimum bid price of $1.00 per share over the required period. This compliance ensures that Canaan’s American depositary shares will remain listed on the Nasdaq Global Market.
The company, which is registered in Singapore and operates in finance services related to crypto assets, had previously been notified by Nasdaq regarding non-compliance with the minimum bid price rule. The recent notification confirms that Canaan has remedied the deficiency.
The information in this article is based on a press release statement contained within the SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.